These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4520391)

  • 1. The alteration of plasma proteins in uremia as reflected in the ability to bind diphenylhydantoin.
    Shoeman DW; Benjamin DM; Azarnoff DL
    Ann N Y Acad Sci; 1973 Nov; 226():127-30. PubMed ID: 4520391
    [No Abstract]   [Full Text] [Related]  

  • 2. The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin.
    Shoeman DW; Azarnoff DL
    Pharmacology; 1972; 7(3):169-77. PubMed ID: 5054587
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients.
    Ehrnebo M; Odar-Cederlöf I
    Eur J Clin Pharmacol; 1975 Aug; 8(6):445-53. PubMed ID: 1233247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding, plasma concentrations, and effects of diphenylhydantoin in man.
    Lund L; Lunde PK; Rane A; Borga O; Sjöqvist F
    Ann N Y Acad Sci; 1971 Jul; 179():723-8. PubMed ID: 4998913
    [No Abstract]   [Full Text] [Related]  

  • 6. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
    Olsen GD; Bennett WM; Porter GA
    Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.
    Reidenberg MM; Odar-Cederlöf I; von Bahr C; Borgå O; Sjöqvist F
    N Engl J Med; 1971 Jul; 285(5):264-7. PubMed ID: 4378402
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered protein binding of diphenylhydantoin in uremic plasma.
    Blum MR; Riegelman S; Becker CE
    N Engl J Med; 1972 Jan; 286(2):109. PubMed ID: 5006870
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
    Odar-Cederlof I
    Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Plasma protein binding and kinetics of diphenylhydantoin in uraemic patients.
    Borga O; Cederlof I
    Acta Pharm Suec; 1974 Dec; 11(6):653-4. PubMed ID: 1136805
    [No Abstract]   [Full Text] [Related]  

  • 11. Alteration of plasma albumin in relation to decreased drug binding in uremia.
    Boobis SW
    Clin Pharmacol Ther; 1977 Aug; 22(2):147-53. PubMed ID: 407044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of plasma concentration determinations: phenytoin.
    Adler DS
    Clin Toxicol; 1979; 14(2):147-50. PubMed ID: 436388
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced in vitro binding of tryptophan by plasma in uremia.
    de Torrente A; Glazer GB; Gulyassy P
    Kidney Int; 1974 Oct; 6(4):222-9. PubMed ID: 4427418
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.
    Odar-Cederlöf I; Borgå O
    Eur J Clin Pharmacol; 1974; 7(1):31-7. PubMed ID: 4852619
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cells.
    Borondy P; Dill WA; Chang T; Buchanan RA; Glazko AJ
    Ann N Y Acad Sci; 1973 Nov; 226():82-7. PubMed ID: 4520405
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro displacement of phenytoin from protein binding by nonsteroidal antiinflammatory drugs tolmetin, ibuprofen, and naproxen in normal and uremic sera.
    Dasgupta A; Timmerman TG
    Ther Drug Monit; 1996 Feb; 18(1):97-9. PubMed ID: 8848829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteins.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Aug; 30(2):276-80. PubMed ID: 7249510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A major inhibitor of phenytoin binding to serum protein in uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma albumin concentration and diphenylhydantoin binding in man.
    Porter RJ; Layzer RB
    Arch Neurol; 1975 May; 32(5):298-303. PubMed ID: 237499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum protein alterations in uremia.
    Morgan JM; Morgan RE; Thomas GE
    Ala J Med Sci; 1967 Jan; 4(1):68-73. PubMed ID: 6036768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.